Kidney ailments which are emerging as a silent killer in India has led Biocon which is one of the largest biotechnology company in the country to launch a series of cheap drugs for treatment of kidney ailments. The drugs were unveiled on World Kidney Day and the firm has plans of selling them in a number of countries worldwide at a price which is thirty percent lesser as compared to the drugs sold by Novartis.

Dubbed as the silent killer of the twenty first century, around 100,000 people in India suffer from renal failure. The one way to avoid catching this disease is to go for regular preventive check ups. Subsequent to being launched in India these drugs would be marketed in Latin America and Persian Gulf region. Some of the companies may even be offered a license for manufacturing these drugs.

Probably this drug may prove to be effective in controlling this disease which is taking the shape of an epidemic.

Via yahoo